Scheres Lotte M J

XENGel Stent compared to PRESERFLO™ MicroShunt implantation for primary open-angle glaucoma: two-year results.

Xen Gel Stent and PreserFlo MicroShunt implantations achieved comparable results in POAG eyes in terms of IOP-lowering and surgical success, with a similar high safety profile.

Five-year follow-up with the PreserFlo MicroShunt for open-angle glaucoma.

After five years, the MicroShunt was found to be a safe procedure, leading to a sustained reduction in mean IOP and number of IOP-lowering medications.